RA Capital Management

Activity in this selectionJun 30, 2026 · Jun 1, 2026

By stage

Series B2

Undisclosed1

Biotech3

United States3

3 in this selection

Jun 24

Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD

$330MSeries B

Role not disclosed

Jun 23

Develops broad-spectrum antiviral prophylactic therapies for respiratory infections

$34MUndisclosed

Role not disclosed

Jun 2

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries B

Role not disclosed